Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
c ebpβ-lip drug

c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP-β LIP and

Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link A) Domain organization of C EBP family members. Each C EBP protein Download Scientific Diagram C EBP regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages Science Immunology A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports

SKU: 46611781141 · From www.asociacionchamorro.org

4.7
USD24.22 USD54.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

nh gi gi c, thng hiu Angel's Liquid l thng hiu m phm n t Hn Quc, ni ting vi cc sn phm dng trng chuyn su, c bit l dng sn phm cha hot cht Glutathione vi nng cao, hng n mc tiu mang li hiu qu lm sng da nhanh chng

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP- LIP and

[DOI] [PMC free article] [PubMed] [Google Scholar] 997.Pacher P, Szabo C

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP- LIP and

The conserved AAA-ATPase Msp1 confers organelle specificity to tail-anchored proteins

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP- LIP and

Aortic pulse wave velocity as a measure of cardiovascular risk in chronic obstructive pulmonary disease: two-year follow-up data from the ARCADE study

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP- LIP and
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Frontiers

US$ 29.12

5.0 (12 reviews)

recommand products

L-Carnitine

US$ 20.06

Min. order: 1 piece

5.0 (24 reviews)

Sold : Login>>